Windy City Retina - Ankit Desai, MD

The scientists discovered that the inhibition of Runt-bound transcription factor 1 (RUNX1), which has been linked to retinal neovascularization and the development of abnormal blood vessels leading to vision loss, presents a new therapy approach to treat age-related macular degeneration (AMD). Their results are published in the American Journal of Pathology . Abnormal growth of blood vessels, or aberrant angiogenesis, originates from the choroid, a portion of the eye behind the retina. This condition, known as choroidal neovascularization (CNV), is present in many eye diseases that lead to blindness like AMD. This study is the first to include RUNX1 in CNV and to test RUNX1 inhibition therapy for the treatment of CNV. The researchers found that the application of a RUNX1 inhibitor alone or in combination with standard therapy for AMD may represent a significant therapeutic advance. The incomplete response to anti-vascular drugs with endothelial growth factor (VEGF) is a critical probl...

Windy city retina is feeling proud to announce that our retina specialist Dr. Ankit Desai has been named in Chicago magazine’s 2021 top doctors list! The physicians were selected as the best in the area by their peers, according to the Chicago magazine and the finalists were chosen based on patient outcomes, education, and professional experience. Congratulations Dr Desai!! 🎉🎉🎉  https://www.chicagomag.com/.../Top-Doctors/Organs-Glands-4/